Contributions of the framingham heart study to stroke and dementia epidemiologic research at 60 years

Archives of Neurology

Volumn 69, Issue 5, 2012, Pages 567-571

  Wolf, Philip A ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; DOCOSAHEXAENOIC ACID; HEMOGLOBIN A1C; HOMOCYSTEINE; PHOSPHATIDYLCHOLINE DOCOSAHEXAENOIC ACID; UNCLASSIFIED DRUG; WARFARIN;

ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CLINICAL RESEARCH; CLINICAL STUDY; COHORT ANALYSIS; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOPHENOTYPE; FOLLOW UP; FRAMINGHAM HEART STUDY; FRAMINGHAM STROKE RISK PROFILE; GENETIC ASSOCIATION; GENOME IMPRINTING; GENOMICS; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT IDENTIFICATION; PATIENT MONITORING; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; REVIEW; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE;

COGNITION DISORDERS; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; STROKE;

EID: 84860901722     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.977     Document Type: Review

References (15)

1. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 2007;6(12):1106-1114. (Pubitemid 350123607)
2. Kannel WB, Dawber TR, Cohen ME, McNamara PM. Vascular disease of the brain-epidemiologic aspects: the Framingham study. Am J Public Health Nations Health. 1965;55:1355-1366.
3. Beckett NS, Peters R, Fletcher AE, et al HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18): 1887-1898. (Pubitemid 351620109)
4. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effect of treatment on morbidity and mortality: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
5. Beckett NS, Peters R, Fletcher AE, et al HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18): 1887-1898. (Pubitemid 351620109)
6. McKee AC, Au R, Cabral HJ, et al. Visual association pathology in preclinical Alzheimer disease. J Neuropathol Exp Neurol. 2006;65(6):621-630. (Pubitemid 44288946)
7. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol. 1993;138(6):353-364. (Pubitemid 23289288)
8. Elias PK, D'Agostino RB, Elias MF, Wolf PA. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res. 1995;21 (4):393-417.
9. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham cohort. Arch Neurol. 2000;57(6):808-813. (Pubitemid 30397182)
10. Seshadri S, Beiser A, Au R, et al. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment: part 2. Alzheimers Dement. 2011;7(1):35-52.
11. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63(11):1545-1550. (Pubitemid 44748796)
12. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology. 2004;63(9):1591-1599. (Pubitemid 39507574)
13. Tan ZS, Beiser AS, Fox CS, et al. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care. 2011;34(8):1766-1770.
14. Ikram MA, Seshadri S, Bis JC, et al. Genomewide association studies of stroke. N Engl J Med. 2009;360(17):1718-1728.
15. Hollingworth P, Harold D, Sims R, et al Alzheimer's Disease Neuroimaging Initiative; CHARGE Consortium; EADI1 Consortium. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-435.